Levophacetoperane
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
[(R)-phenyl-[(2R)-piperidin-2-yl]methyl] acetate
|
|
| Clinical data | |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 24558-01-8  |
| ATC code | None |
| PubChem | CID: 65715 |
| Chemical data | |
| Formula | C14H19NO2 |
| Molecular mass | 233.31 g/mol |
|
|
| (verify) |
Levophacetoperane (Lidépran,Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate. The reverse esters of many drugs which contain an ester group in their structure such as pethidine and cocaine show similar activity to the parent compound.[4]
See also[edit]
References[edit]
- ^ US Patent 2928835 - New Esters
- ^ Delbeke FT, Debackere M. Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping. I. Gas chromatographic detection procedure with electron capture detection for some secondary amines. Journal of Chromatography. 1975 Mar 26;106(2):412-7.
- ^ O'Neil, Maryadele J. (2001). The Merck index: an encyclopedia of chemicals, drugs, and biologicals. Rahway, NJ: Merck Research Laboratories. ISBN 0-911910-13-1.
- ^ Janssen PAJ, Eddy NB. Compounds Related to Pethidine - IV. New General Chemical Methods of Increasing the Analgesic Activity of Pethidine. Journal of Medicinal and Pharmaceutical Chemistry. 1960; 2(1): 31-45.
|
|
|
|
 |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
